social media

Latest Headlines

Latest Headlines

Want to get a warning letter from OPDP? Omit drug risks from your promos

Sometimes it seems that the FDA has a scattershot approach to policing pharma marketing, with warning letters few and far between--and some of them lobbed from left field. But there's one tried-and-true way to invite unwanted attention from the agency's marketing police: Leave side effects out of drug promos, according to an analysis presented at a recent conference.

Turing Pharma price hike debacle tars entire pharma industry's reputation

How much damage can one person do? In the case of the pharma industry this week, the answer was quite a lot. That one person was Martin Shkreli, the CEO of Turing Pharmaceuticals, who hiked the price of its newly purchased toxoplasmosis drug Daraprim by more than 5000%. Universal social media criticism and outrage over "price gouging" followed, along with a financial hit to biotech stocks.

Rough waters for pharma's U.S. pricing power, yes. Sea change? Nope

This could go down in pharma history as the week that drug pricing met pop culture. But this week won't be remembered as the one when drugmakers lost their long-standing pricing power in the U.S. That, at least, was the word from analysts and at least one top pharma CEO as politicians vowed a crackdown.

More followers and more daily tweeting as Big Pharma's Twitter presence grows

Tweet on, drugmakers. Not only is Twitter use by pharma companies on the rise, but so is interest in what they've got to say. A recent survey by the Eye on FDA blog found more daily interactions on Twitter by pharma, along with a marked increase in followers versus last year.

Kardashian's FDA infraction shows policing pharma social media isn't easy

Are pharma social media FDA infractions slipping through the cracks? It took more than three weeks for the FDA to notice Kim Kardashian's regulation-bending Instagram post paid for by anti-morning sickness drug Duchesnay's Diclegis. Similar misleading claims on social media might be going unnoticed altogether,  Vox  suggests.

The 'Kardashian Effect' on pharma begs the question: Does social media influence drug requests?

The "Kardashian Effect"--it's a term to describe the way reality TV's Kardashian family, especially daughter Kim, influences beauty and fashion trends. Now, the Kardashian Effect has come to pharma.

Abbott, Novartis tap into #ILookLikeAnEngineer social media movement

Stereotyping in male-dominated professions like engineering is nothing new. But one young female engineer in San Francisco had enough, after she appeared in an ad for her company--and then faced a backlash on social media. She didn't look like an engineer, the critics said.

Pharma leaves ad agencies behind for in-house digital marketing teams

Brands are ditching agencies and bringing digital marketing in-house in bigger numbers than ever, and that includes pharma companies. A new study from the Society of Digital Agencies found that "the percentage of clients taking full responsibility for digital efforts at their companies grew significantly" year over year.

Top 10 pharma companies in social media

Social media success in consumer marketing has advanced beyond counting fans and followers. Today it's all about shares, retweets and links that indicate real consumer engagement with brands....

Congressman pushes to unshackle pharma on social media

A congressman is taking aim at perceived flaws in FDA's long-awaited, much-discussed guidance on the use of Twitter.